RNASE3 and allergic disease: Therefore, the PI3K/Akt/mTOR pathway serves as a crucial regulator of eosinophil survival, activation, and degranulation, making it a potential therapeutic target for controlling eosinophil function and ECP release to thereby reduce tissue damage and alleviate the symptoms of inflammatory and allergic diseases.